Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
Gwénola Boulday, Noemi Rudini, Luigi Maddaluno, Anne Blécon, Minh Arnould, Alain Gaudric, Françoise Chapon, Ralf H Adams, Elisabetta Dejana, Elisabeth Tournier-Lasserve, Gwénola Boulday, Noemi Rudini, Luigi Maddaluno, Anne Blécon, Minh Arnould, Alain Gaudric, Françoise Chapon, Ralf H Adams, Elisabetta Dejana, Elisabeth Tournier-Lasserve
Abstract
Cerebral cavernous malformations (CCM) are vascular malformations of the central nervous system (CNS) that lead to cerebral hemorrhages. Familial CCM occurs as an autosomal dominant condition caused by loss-of-function mutations in one of the three CCM genes. Constitutive or tissue-specific ablation of any of the Ccm genes in mice previously established the crucial role of Ccm gene expression in endothelial cells for proper angiogenesis. However, embryonic lethality precluded the development of relevant CCM mouse models. Here, we show that endothelial-specific Ccm2 deletion at postnatal day 1 (P1) in mice results in vascular lesions mimicking human CCM lesions. Consistent with CCM1/3 involvement in the same human disease, deletion of Ccm1/3 at P1 in mice results in similar CCM lesions. The lesions are located in the cerebellum and the retina, two organs undergoing intense postnatal angiogenesis. Despite a pan-endothelial Ccm2 deletion, CCM lesions are restricted to the venous bed. Notably, the consequences of Ccm2 loss depend on the developmental timing of Ccm2 ablation. This work provides a highly penetrant and relevant CCM mouse model.
© 2011 Boulday et al.
Figures
References
- Acker T., Beck H., Plate K.H. 2001. Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization. Mech. Dev. 108:45–57 10.1016/S0925-4773(01)00471-3
- Akers A.L., Johnson E., Steinberg G.K., Zabramski J.M., Marchuk D.A. 2009. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum. Mol. Genet. 18:919–930
- Balconi G., Spagnuolo R., Dejana E. 2000. Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 20:1443–1451 10.1161/01.ATV.20.6.1443
- Beck H., Plate K.H. 2009. Angiogenesis after cerebral ischemia. Acta Neuropathol. 117:481–496 10.1007/s00401-009-0483-6
- Bergametti F., Denier C., Labauge P., Arnoult M., Boetto S., Clanet M., Coubes P., Echenne B., Ibrahim R., Irthum B., et al. ; SociétéFrançaise de Neurochirurgie 2005. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 76:42–51 10.1086/426952
- Boulday G., Blécon A., Petit N., Chareyre F., Garcia L.A., Niwa-Kawakita M., Giovannini M., Tournier-Lasserve E. 2009. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis Model Mech. 2:168–177 10.1242/dmm.001263
- Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857–868 10.1016/S0092-8674(00)80595-4
- Burgering B.M., Kops G.J. 2002. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:352–360 10.1016/S0968-0004(02)02113-8
- Chan A.C., Drakos S.G., Ruiz O.E., Smith A.C., Gibson C.C., Ling J., Passi S.F., Stratman A.N., Sacharidou A., Revelo M.P., et al. 2011. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J. Clin. Invest. 121:1871–1881 10.1172/JCI44393
- Clatterbuck R.E., Eberhart C.G., Crain B.J., Rigamonti D. 2001. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J. Neurol. Neurosurg. Psychiatry. 71:188–192 10.1136/jnnp.71.2.188
- Craig H.D., Günel M., Cepeda O., Johnson E.W., Ptacek L., Steinberg G.K., Ogilvy C.S., Berg M.J., Crawford S.C., Scott R.M., et al. 1998. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum. Mol. Genet. 7:1851–1858 10.1093/hmg/7.12.1851
- Cunningham K., Uchida Y., O’Donnell E., Claudio E., Li W., Soneji K., Wang H., Mukouyama Y.S., Siebenlist U. 2011. Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations. Hum. Mol. Genet. 20:3198–3206
- Daly C., Wong V., Burova E., Wei Y., Zabski S., Griffiths J., Lai K.M., Lin H.C., Ioffe E., Yancopoulos G.D., Rudge J.S. 2004. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18:1060–1071 10.1101/gad.1189704
- Dejana E. 2010. The role of wnt signaling in physiological and pathological angiogenesis. Circ. Res. 107:943–952 10.1161/CIRCRESAHA.110.223750
- Denier C., Goutagny S., Labauge P., Krivosic V., Arnoult M., Cousin A., Benabid A.L., Comoy J., Frerebeau P., Gilbert B., et al. ; SociétéFrançaise de Neurochirurgie 2004. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 74:326–337 10.1086/381718
- Denier C., Labauge P., Bergametti F., Marchelli F., Riant F., Arnoult M., Maciazek J., Vicaut E., Brunereau L., Tournier-Lasserve E.; SociétéFrançaise de Neurochirurgie 2006. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 60:550–556 10.1002/ana.20947
- Dong Q.G., Bernasconi S., Lostaglio S., De Calmanovici R.W., Martin-Padura I., Breviario F., Garlanda C., Ramponi S., Mantovani A., Vecchi A. 1997. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17:1599–1604 10.1161/01.ATV.17.8.1599
- Dorrell M.I., Friedlander M. 2006. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog. Retin. Eye Res. 25:277–295 10.1016/j.preteyeres.2006.01.001
- Faurobert E., Albiges-Rizo C. 2010. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 277:1084–1096 10.1111/j.1742-4658.2009.07537.x
- Fischer E., Legue E., Doyen A., Nato F., Nicolas J.F., Torres V., Yaniv M., Pontoglio M. 2006. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38:21–23 10.1038/ng1701
- Fontijn R.D., Volger O.L., Fledderus J.O., Reijerkerk A., de Vries H.E., Horrevoets A.J. 2008. SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am. J. Physiol. Heart Circ. Physiol. 294:H891–H900 10.1152/ajpheart.01248.2007
- Fruttiger M. 2007. Development of the retinal vasculature. Angiogenesis. 10:77–88 10.1007/s10456-007-9065-1
- Gault J., Shenkar R., Recksiek P., Awad I.A. 2005. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke. 36:872–874 10.1161/01.STR.0000157586.20479.fd
- Glading A.J., Ginsberg M.H. 2010. Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis. Model Mech. 3:73–83 10.1242/dmm.003293
- Glading A., Han J., Stockton R.A., Ginsberg M.H. 2007. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 179:247–254 10.1083/jcb.200705175
- He Y., Zhang H., Yu L., Gunel M., Boggon T.J., Chen H., Min W. 2010. Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci. Signal. 3:ra26 10.1126/scisignal.2000722
- Hilder T.L., Malone M.H., Bencharit S., Colicelli J., Haystead T.A., Johnson G.L., Wu C.C. 2007. Proteomic identification of the cerebral cavernous malformation signaling complex. J. Proteome Res. 6:4343–4355 10.1021/pr0704276
- Hogan B.M., Bussmann J., Wolburg H., Schulte-Merker S. 2008. ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 17:2424–2432 10.1093/hmg/ddn142
- Karner C.M., Chirumamilla R., Aoki S., Igarashi P., Wallingford J.B., Carroll T.J. 2009. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat. Genet. 41:793–799 10.1038/ng.400
- Labauge P., Denier C., Bergametti F., Tournier-Lasserve E. 2007. Genetics of cavernous angiomas. Lancet Neurol. 6:237–244 10.1016/S1474-4422(07)70053-4
- Laberge-le Couteulx S., Jung H.H., Labauge P., Houtteville J.P., Lescoat C., Cecillon M., Marechal E., Joutel A., Bach J.F., Tournier-Lasserve E. 1999. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23:189–193 10.1038/13815
- Lampugnani M.G., Orsenigo F., Rudini N., Maddaluno L., Boulday G., Chapon F., Dejana E. 2010. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J. Cell Sci. 123:1073–1080 10.1242/jcs.059329
- Leblanc G.G., Golanov E., Awad I.A., Young W.L.; Biology of Vascular Malformations of the Brain NINDS Workshop Collaborators 2009. Biology of vascular malformations of the brain. Stroke. 40:e694–e702 10.1161/STROKEAHA.109.563692
- Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., et al. 2008. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 183:409–417 10.1083/jcb.200806024
- Liquori C.L., Berg M.J., Siegel A.M., Huang E., Zawistowski J.S., Stoffer T., Verlaan D., Balogun F., Hughes L., Leedom T.P., et al. 2003. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 73:1459–1464 10.1086/380314
- Louvi A., Chen L., Two A.M., Zhang H., Min W., Günel M. 2011. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc. Natl. Acad. Sci. USA. 108:3737–3742 10.1073/pnas.1012617108
- Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., Volpin D., Bressan G.M., Piccolo S. 2003. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA. 100:3299–3304 10.1073/pnas.0434590100
- McDonald D.A., Shenkar R., Shi C., Stockton R.A., Akers A.L., Kucherlapati M.H., Kucherlapati R., Brainer J., Ginsberg M.H., Awad I.A., Marchuk D.A. 2011. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum. Mol. Genet. 20:211–222 10.1093/hmg/ddq433
- Morita K., Sasaki H., Furuse M., Tsukita S. 1999. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147:185–194 10.1083/jcb.147.1.185
- Nonaka H., Akima M., Hatori T., Nagayama T., Zhang Z., Ihara F. 2002. The microvasculature of the human cerebellar meninges. Acta Neuropathol. 104:608–614
- Pagenstecher A., Stahl S., Sure U., Felbor U. 2009. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum. Mol. Genet. 18:911–918
- Peitz M., Pfannkuche K., Rajewsky K., Edenhofer F. 2002. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. USA. 99:4489–4494 10.1073/pnas.032068699
- Petit N., Blécon A., Denier C., Tournier-Lasserve E. 2006. Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr. Patterns. 6:495–503 10.1016/j.modgep.2005.11.001
- Piontek K., Menezes L.F., Garcia-Gonzalez M.A., Huso D.L., Germino G.G. 2007. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13:1490–1495 10.1038/nm1675
- Pitulescu M.E., Schmidt I., Benedito R., Adams R.H. 2010. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 5:1518–1534 10.1038/nprot.2010.113
- Plate K.H. 1999. Mechanisms of angiogenesis in the brain. J. Neuropathol. Exp. Neurol. 58:313–320 10.1097/00005072-199904000-00001
- Plummer N.W., Gallione C.J., Srinivasan S., Zawistowski J.S., Louis D.N., Marchuk D.A. 2004. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am. J. Pathol. 165:1509–1518 10.1016/S0002-9440(10)63409-8
- Riant F., Bergametti F., Ayrignac X., Boulday G., Tournier-Lasserve E. 2010. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 277:1070–1075 10.1111/j.1742-4658.2009.07535.x
- Russel D.S., Rubinstein L.J. 1989. Pathology of Tumors of the Nervous System. Williams & Wilkins, editor Baltimore, MD: p. 730–736
- Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70–71 10.1038/5007
- Stockton R.A., Shenkar R., Awad I.A., Ginsberg M.H. 2010. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 207:881–896 10.1084/jem.20091258
- Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., Potente M., Daly C., Dimmeler S., Dejana E. 2008. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 10:923–934 10.1038/ncb1752
- Verdeguer F., Le Corre S., Fischer E., Callens C., Garbay S., Doyen A., Igarashi P., Terzi F., Pontoglio M. 2010. A mitotic transcriptional switch in polycystic kidney disease. Nat. Med. 16:106–110 10.1038/nm.2068
- Wang H.U., Chen Z.F., Anderson D.J. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:741–753 10.1016/S0092-8674(00)81436-1
- Wang Y., Nakayama M., Pitulescu M.E., Schmidt T.S., Bochenek M.L., Sakakibara A., Adams S., Davy A., Deutsch U., Lüthi U., et al. 2010. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 465:483–486 10.1038/nature09002
- Whitehead K.J., Plummer N.W., Adams J.A., Marchuk D.A., Li D.Y. 2004. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development. 131:1437–1448 10.1242/dev.01036
- Whitehead K.J., Chan A.C., Navankasattusas S., Koh W., London N.R., Ling J., Mayo A.H., Drakos S.G., Jones C.A., Zhu W., et al. 2009. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15:177–184 10.1038/nm.1911
- Yadla S., Jabbour P.M., Shenkar R., Shi C., Campbell P.G., Awad I.A. 2010. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg. Focus. 29:E4 10.3171/2010.5.FOCUS10121
- Yu B.P., Yu C.C., Robertson R.T. 1994. Patterns of capillaries in developing cerebral and cerebellar cortices of rats. Acta Anat. (Basel). 149:128–133 10.1159/000147567
- Zawistowski J.S., Stalheim L., Uhlik M.T., Abell A.N., Ancrile B.B., Johnson G.L., Marchuk D.A. 2005. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 14:2521–2531 10.1093/hmg/ddi256
- Zeng G., Taylor S.M., McColm J.R., Kappas N.C., Kearney J.B., Williams L.H., Hartnett M.E., Bautch V.L. 2007. Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood. 109:1345–1352 10.1182/blood-2006-07-037952
- Zhang X., Gan L., Pan H., Guo S., He X., Olson S.T., Mesecar A., Adam S., Unterman T.G. 2002. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J. Biol. Chem. 277:45276–45284 10.1074/jbc.M208063200
- Zovein A.C., Luque A., Turlo K.A., Hofmann J.J., Yee K.M., Becker M.S., Fassler R., Mellman I., Lane T.F., Iruela-Arispe M.L. 2010. Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. Dev. Cell. 18:39–51 10.1016/j.devcel.2009.12.006
Source: PubMed